Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Insel Gruppe AG, University Hospital Bern | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to assess the association of biomarkers on day 7 of life with the development of bronchopulmonary dysplasia in very preterm infants. Additionally a short lung function test at 36 weeks postmenstrual age (PMA) will be performed to investigate whether certain capnographic indices are able to reflect the degree of lung disease.
Protocol was amended (under others: additional enrollment of 70 subjects).
This is a two-centre prospective cohort study in very preterm infants born below 32 0/7 weeks PMA and hospitalised in the neonatal intensive care units at the University Children's Hospital Basel and the Inselspital Berne during two years. After informed consent a sample of 0.5 mL ethylenediaminetetraacetic acid (EDTA) full blood will be taken on day 7 of life (+/- 2 days) during routine blood sampling. The biomarkers which are planned to measure include the C-terminal portion of the proendothelin-1 precursor (CT-proendothelin (proET)-1) and other plasma biomarkers of respiratory distress. At 36 weeks PMA, lung function testing will be performed during quiet unsedated sleep in supine position approximately 30 minutes post feeding. After placement of a facemask, tidal breathing will be recorded at the bedside using a commercially available ultrasonic flow meter (Spiroson, Exhalyzer D, Ecomedics, CH) according to American Thoracic Society (ATS) and European Respiratory Society (ERS) standards of infant lung function testing. Different capnographic indices will be calculated to investigate if they reflect the degree of lung disease at 36 weeks PMA.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| association of plasma biomarker levels (pro-endothelin-1 precursor and other markers of respiratory distress) with the duration of supplemental oxygen dependancy in infancy | Assessment at 36 weeks PMA or until the end of supplemental oxygen dependancy assessed up to 12 months | |
| association of capnographic indices with the duration of supplemental oxygen dependancy | Capnographic indices include expired carbon dioxide volume per breath, slopes of phase II (SII) and slopes of phase III (SIII) of the capnogram. | 36 weeks PMA or until the end of supplemental oxygen dependancy assessed up to 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| several definitions of BPD | 36 weeks PMA | |
| duration of respiratory support | participants will be followed for the duration of hospital stay, an expected average of 12 weeks | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Preterm infants born below 32 weeks PMA and admitted to the neonatal intensive care units in Basel and Berne, Switzerland.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Roland P Neumann, MD | Department of Neonatology, University Children's Hospital Basel, Basel, Switzerland | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Neonatology, University Children's Hospital Basel | Basel | 4031 | Switzerland | |||
| Department of Neonatology, Inselpital Berne |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 34687691 | Derived | Neumann RP, Gerull R, Zannin E, Fouzas S, Schulzke SM. Volumetric Capnography at 36 Weeks Postmenstrual Age and Bronchopulmonary Dysplasia in Very Preterm Infants. J Pediatr. 2022 Feb;241:97-102.e2. doi: 10.1016/j.jpeds.2021.10.019. Epub 2021 Oct 24. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001997 | Bronchopulmonary Dysplasia |
| D047928 | Premature Birth |
| ID | Term |
|---|---|
| D055397 | Ventilator-Induced Lung Injury |
| D055370 | Lung Injury |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Plasma
| death |
| participants will be followed for the duration of hospital stay, an expected average of 12 weeks |
| sepsis | participants will be followed for the duration of hospital stay, an expected average of 12 weeks |
| necrotizing enterocolitis (NEC) | participants will be followed for the duration of hospital stay, an expected average of 12 weeks |
| retinopathy of prematurity (ROP) | until completion of retinal vascularization or up to 6 months, whichever came first |
| intraventricular hemorrhage (IVH) | participants will be followed for the duration of hospital stay, an expected average of 12 weeks |
| patent ductus arteriosus | participants will be followed for the duration of hospital stay, an expected average of 12 weeks |
| Bern |
| 3010 |
| Switzerland |
| D007235 |
| Infant, Premature, Diseases |
| D007232 | Infant, Newborn, Diseases |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D007752 | Obstetric Labor, Premature |
| D007744 | Obstetric Labor Complications |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |